SCREENING OF
PREGNANT WOMEN FOR GESTATIONAL DIABETES MELLITUS
Department of Gynaecology, Ayub Teaching Hospital, Abbottabad
Background: Gestational diabetes mellitus is
associated with significant fetal and neonatal morbidity and mortality. It is a
definitive risk factor for the future development of type – II diabetes
mellitus in the mother. Our objective
was to evaluate the effectiveness of screening by 50gm oral glucose challenge
test to detect the gestational diabetes mellitus and impaired glucose tolerance
in pregnant women. Methods:
This study was conducted in the Department of Gynaecology
at
Key Words: Gestational Diabetes Mellitus, Impaired Glucose
Tolerance, Oral Glucose Challenge Test, Full Oral Glucose Tolerance test
Introduction
Gestational Diabetes Mellitus is
the most common metabolic disorder affecting carbohydrates homeostasis.1
It appears at ≥ 20 weeks gestation and disappears immediately or up to 6
weeks after delivery.2 It is associated with high risk of fetal
morbidity and mortality and also leaves the mother at potential risk of
developing overt diabetes at an advanced age.
Increased risk of fetal compromise comes from maternal hyperglycemia,
which leads to fetal hyperglycemia and fetal hyperinsulinaemia.
Fetal hyperinsulinaemia accelerates fetal growth,
facilitated by rich pool of metabolic substrates in addition to glucose. In
addition to tremendous fetal growth and organomegaly,
hyperinsulinaemia also leads to biochemical
abnormalities like anaerobic glucose metabolism, increased oxygen consumption,
lactate production and fall in PH and oxygen tension. This gives rise to a
variety of problems to the infant of diabetic mother like sudden intra uterine
death, respiratory distress syndrome, hypoglycaemia, cardiomyopathies,
neonatal jaundice, impaired calcium and magnesium homeostasis, polycythemia and many more4.
Mother may
develop pre eclampsia, hypoglycaemia
due to stringent blood sugar control necessary in pregnancy or diabetic keto acidosis. In the long term she remains a potential
candidate to develop type – II diabetes mellitus.
Detection
and treatment of Gestational Diabetes Mellitus (GDM) not only reduces and
eliminates the risks for the fetus, it also provides an opportunity to warn the
mother to adopt preventative measures like controlled diet, exercise and
achieve ideal body weight, to halt or delay the process of onset of overt
diabetes. 5
Since GDM,
is an asymptomatic disorder and needs some sort of screening tools for its
detection, we endeavored to evaluate the applicability of 50gm of oral glucose
challenge test (OGCT). This test has a sensitivity of 80% and a specificity of
90% and a positive predictive value of 85% which is superior to any other
screening test7. Alternative screening protocols are based on blood
include glycosylated haemoglobin
(HBA1c) estimation and timed random blood glucose estimation8.
Glycosylated hemoglobin estimation is costly and has
low sensitivity. Timed random blood glucose estimation is relatively cheap, and fairly specific but lacks sensitivity9.
Our objective was to evaluate the effectiveness of screening by 50gm oral
glucose challenge test to detect the gestational diabetes mellitus and impaired
glucose tolerance in pregnant women.
MATERIAL
AND Methods
This study was carried
out from March to December 1997. Patients were included in the study from a
broad obstetric population regardless of presence or absence of classical
gestational diabetes risk factors like maternal advanced age, parity, obesity,
recurrent pregnancy loss, congenital malformations, intrauterine death, polyhydramnios, prolonged difficult labour,
operative deliveries associated with heavier neonates, still births and
neonatal deaths, and family history of diabetes.
A total of
1000 pregnant women attending antenatal clinic in outdoors Department of
Data was recorded in a proforma including
patient’s age, height, weight, gestational age,
detailed menstrual, obstetric and medical history. Record of blood pressure,
general physical and systemic examination and obstetric examination was also
included. According
to the standard height and weight and body mass index tables, women with weight
< 80% of ideal body weight were regarded as under weight. Those with weight
between 80 – 120% were normal and women with >120% were moderately obese and
those with >150% were severely obese. A sample of blood drawn one hour after glucose ingestion was sent to the
laboratory for blood glucose estimation by glucose oxidase
hexokinase method. A blood glucose level of 130mg/dl
was taken as cut off value for further evaluation of the patient by 100gm Oral Glucose
Tolerance test (OGTT) and confirmation of the diagnoses of GDM
or IGT. Before the OGTT patients were advised to have rich carbohydrate diet
for at least three days and present at the morning of the test with an
overnight 12 hours fast. Patients who had two or more abnormal glucose values
equal to or exceeding the defined National diabetes data group criteria were
labeled to have gestational diabetes and those with only one abnormal value
impaired glucose tolerance.
Patients who were screen positive before 28 weeks but OGTT negative or
screen negative but had historic high risk factors for GDM were re-screened at
28 weeks. The re-screened positive were subjected to repeat OGTT and those with
positive results were reclassified to have GDM or IGT according to the report
while rest were declared normal and followed in low risk antenatal clinic.
Those diagnosed to have GDM or IGT were followed in high risk clinic for
maternal blood glucose control in normal range of 80 – 120 mg/dl by diet alone,
diet and exercise or insulin therapy and for strict fetal monitoring throughout
the pregnancy. Mothers were watched for the development of complication like
urinary and genital tract infection and pre-eclampsia.
Fetal monitoring was done by fetal kick count record; serial ultrasound scans
for fetal growth, biophysical profiles and amniotic fluid volume. Timing and
mode of delivery of the patient was decided according to set protocols for
diabetic mothers.
The detailed description of their follow up till the delivery and sixth
week of puerperium is beyond the scope of study and
is not included here.
Results
Out of 1000 patients screened with 50gm OGCT, 266
(22.6%) exhibited plasma glucose level of ≥130mg/dl and were declared as
screen positive. All the 266 patients were enrolled for a three hours 100gm
OGTT. Out of 266 patients 37(16.3%) had two abnormal values on OGTT and were
diagnosed to have GDM, while another 14(6.2%) patients had only one abnormal
value on OGTT and were diagnosed to have IGT. All the patients who were screen
positive before 28 weeks but OGTT negative and had high-risk historic features of potential
diabetes were advised to present again at or after 28 weeks for re screening.
Total number of patients who presented for re-screening were
70, out of whom 17(24.3%) patients were again screen positive after 50gm OGCT.
They were again enrolled for 100gm OGTT and further 6 (35.3%)cases
of GDM and 3 (17.65%) cases of IGT were detected. The overall incidence of GDM
was 43 per 1000 cases (4.3%) and that of IGT was 17 per 1000 cases (1.7%). The
result is summarized in Table-1 and Table -2.
Table-1:
Result of screening, re-screening, OGTT & repeat OGTT
Results |
Total Cases |
Screen
Positive |
Screen
Negative |
GDM Two
abnormal values on OGTT |
IGT One
abnormal value on OGTT |
||||
No. |
% |
No. |
% |
No. |
% |
No. |
% |
||
Cases picked up after initial screening &
OGTT |
1000 |
226 |
22.6 |
774 |
77.4 |
37 |
16.3 |
14 |
6.20 |
Cases picked up after re-screening & OGTT |
70 |
17 |
24.3 |
53 |
75.7 |
06 |
35.3 |
03 |
17.65 |
Table-2: Over all incidence of gdm
& igt
Type of
Abnormality |
Cases picked up after initial screening & OGTT |
Cases picked up after re-screening & OGTT |
Incidence |
||||||
No. |
Total |
% |
No. |
Total |
% |
No. |
Total |
% |
|
GDM |
37 |
1000 |
3.7 |
6 |
70 |
8.75 |
43 |
1000 |
4.3 |
IGT |
14 |
1000 |
1.4 |
3 |
70 |
4.28 |
17 |
1000 |
1.7 |
Figure-1 shows risk factors
identified in obstetric history of the patients diagnosed to have GDM or IGT.
History of stillbirths was present in 7(41.3%) out of 17 cases of IGT and 12
(28%) out of 43 cases of GDM. Also more macrosomic
babies, 4 (23.6%)out of 17 cases were detected in the
past obstetric history of IGT group than 3 cases of macrosomia
out of 43 cases (7%) of GDM vis-ŕ-vis (23% versus 7%). History of neonatal
deaths was present in 12 out of 43 (28%) patients of GDM and 3 out of 17
(17.7%) patients of IGT. Other risk factors noted in the patient’s histories
were prolonged labour (18.6%), operative and
instrumental vaginal deliveries (9.3%), pre-eclampsia
(9.3%) antepartam hemorrhage (4.65%), intrauterine
deaths (2.35%) and polyhydramnios (2.35%).
Fig-1: High Risk Factors in Previous Obstetric History
of the Patients
A total of 750 (75%) cases were screened at
the age of 20-30 years and 247 (24.7%) cases were more than 35 years of age.
Only 3 cases (0.3%) were 19 or less. Out of them 37 cases (4.93%) of GDM and 14
cases of IGT (1.86%) were diagnosed at the younger age group of 20-35 years;
whereas 6 cases (2.42%) of GDM and 3 cases of IGT (1.21%) out of 247 cases were
detected above the age of 35 years. The mean maternal age of the patients with
GDM and IGT was 30.42 years. With regard to parity 4 cases (1.29%) of GDM and 2
cases (0.64%) of IGT were detected in primigravida,
30 cases (5.45%) of GDM and 13 cases (2.36%) of IGT were detected in multigravida and 9 cases (6.42%) of GDM and 2 cases (1.42%)
of IGT were detected in grandmultigrvida. In this
study more than 75 % were multigravida, 21% were grandmultigravida and about 12 % patients were primigravida. GDM was detected in 28 (3.58%) and IGT in 13
(1.66%) out of 780 (78%) total patients screened before 28 weeks of gestation,
whereas after 28 weeks, 15 (6.81%) cases of GDM and 4 (1.81%) cases of IGT out of total of 220
(22%) cases were detected. Mean gestation of the patients with GDM and IGT was
25.46 weeks and 27 weeks respectively. In our series 616 patients had a normal
weight, 361 were moderately obese and 23 patients were severely obese. These
values were corrected for pregnancy and period of gestation. Out of 23 severely
obese patients, 5 (21.7%) patients had GDM and 2 (8.7%) patients had IGT.
Amongst moderately obese 261 patients, 12 (4.6%) patients had GDM and 6(2.3%)
had IGT. In our series overall rate of obesity was 38-40%. The patient’s
characteristics like age, parity, gestational age and weight distribution and
degree of obesity of 1000 patients are shown in table-3.
Table-3: Patients characteristics
AGE |
NO. OF
CASES |
GDM |
% |
IGT |
% |
19 or
less |
3 |
Nil |
Nil |
Nil |
Nil |
20 – 35
years |
750 |
37 |
4.93 |
14 |
1.86 |
> 35
years |
247 |
6 |
2.42 |
3 |
1.21 |
Total |
1000 |
43 |
4.3 |
17 |
1.7 |
P a r i t y |
|||||
Primigravida |
310 |
4 |
1.29 |
02 |
0.64 |
Multigravida |
550 |
30 |
5.45 |
13 |
2.36 |
Grandmultigravida |
140 |
09 |
6.42 |
02 |
1.42 |
Total |
1000 |
43 |
4.3 |
17 |
1.7 |
Gestational Age |
|||||
29 – 36 weeks |
220 |
15 |
6.81 |
04 |
1.81 |
24 – 28
weeks |
780 |
28 |
3.58 |
13 |
1.66 |
Total |
1000 |
43 |
4.3 |
17 |
1.7 |
Weight Distribution & Degree Of Obesity |
|||||
Moderate
> 120% |
261 |
12 |
4.6 |
06 |
2.3 |
Severe
> 150% |
23 |
5 |
21.7 |
02 |
8.7 |
Normal
b/w 80 – 120% |
616 |
26 |
4.2 |
09 |
1.4 |
Total |
1000 |
43 |
4.3 |
17 |
1.7 |
Discussion
In our study out of 1000 patients, 266 were screened
positive in contrast to 60-63 per 1000 in most World Series. Similarly,
diabetes complicates 3-4 per 1000 pregnancies in most World Series, but where
intensive screening has become part of routine antenatal care; more cases are
being detected with a range of 1 - 12 per 1000 obstetric cases. However, it
varies among different populations of different geographical origins and ethnic
backgrounds.10,11
In our study frequency of GDM was 43 per
1000 (4.3%) pregnancies and incidence of IGT was 17 per 1000 (1.7%) cases. Thus
disorders of glucose intolerance can be regarded as diseases of developing
countries.12 Some of the local factors
contributing to this high incidence are poverty and ignorance. People are
usually not aware of nutritional and caloric values of food and implications on
body weight and health. Carbohydrate based food is cheap and taken as staple
diet, whereas fats are used to add to the taste of the food. Moreover, lack of
awareness regarding weight control puts them in the habit of excessive eating.
The situation is further accentuated during pregnancy, wherein the women are
customarily advised to take the food for ‘ two’. This
leads to obesity and unfortunately, this is taken as a sign of beauty and
health in most of rural population. These facts puts our population at higher
risk for the development of diabetes and the importance of intensive screening
for the detection of pre-clinical disease cannot be over estimated 11,12.
The existence of
a pre diabetic state was postulated in these patients about 20 years back but
remained disputed on grounds that a disorder causing such a measurable degree
of morbidity cannot escape detection on routine blood sugar testing. Such high
risk factors were present in obstetric histories of most of our patients
diagnosed to have GDM or IGT 14.
In GDM group 17 patients out of 43 and in IGT group 11 patients out of
17 had historic risk factors, which constitutes 36 –
42 % of the patients with the disease having historic risk factors. It is
consistent with international studies, which report that only 45% of women
found to have carbohydrate intolerance have defined features of potential
diabetes. It signifies that accepted practice in antenatal clinics, of only
performing a GTT on a mother if she has one of the features of potential
diabetes is both time consuming and incomplete and 55-58% of the cases may be
missed15.
Screening system is the system originally
proposed by O’Sullivan and Mahan et al. They suggested that single OGCT is not
reliable; re-screening must be done in patients after 28 weeks of gestation who
had historic risk factors present13. In our series, re-screening yielded
another 6 per 1000 (35.3%) cases of GDM and 3 per 1000 (17.65%) cases of IGT. Thus overall, rescreening yielded a greater percentage of cases of GDM
(35.3% verses 16.3%) and IGT (17.65% verses 6.20%) in comparison with the
initial screen. All these data are consistent with international studies.
The mean age of the
patients detected to have GDM and IGT was 30.42 years in our study, which was
consistent with most world studies in which it is regarded as the disease
affecting the women at an advance age.10,11
In our study women over the age of 35 years were significantly less. It is
because less women opt for pregnancy during the later
years of life, although more of them develop overt diabetes mellitus. In our
series none of the patients was underweight and a high percentage of positive
patients (21.7%vs 4.6%in GDM group and 8.7% vs 2.3%
in IGT group) belonged to severely obese in comparison to moderately obese
patients. Over all rate of obesity was 38 – 40%, which is quite high and is
consistent with most world records10,11. In our study, significantly higher percentage
(6.81% vs 3.58% in GDM group and 1.81% vs 1.66% in IGT group) of cases was detected at an advance
gestational age beyond 28 weeks. It is because the glucose intolerance
increases with advancing gestational age. The patients with healthier pancreas
are detected after 32 weeks of gestation. These findings are consistent
with international reports15. A higher percentage 6.42%(n
= 9) of cases of GDM were grandmultigravida compared
to 5.45 % (n =30) multigravida and only 1.29% (n= 4) primigravida. In IGT group percentage of multigravida is 2.36% (n = 13), which exceeds that of grandmultigravida of 1.42% (n =2). This effect is because
the total number of patients with grandmultiparity
was less in our series. These results are in accordance with international
reports from highly prevalent areas
11,12,14. Family history for a variety of risk factors and association with other
disorders like pre-eclampsia was present in many
cases as is reported in other studies.15,16
Conclusions
Our results suggest that a
policy of universal screening for GDM should be adopted in all antenatal
clinics and 50gm OGCT is a test with high predictive value. As in this study
significant proportion of the cases was detected on re-screening and repeat
OGTT, it is emphasized that re-screening at a later gestation of 28 weeks or
beyond must form an essential component of screening. It will not only improve the perinatal outcome but also enable us to identify women at
risk of developing diabetes in future. These potential diabetic women can be
warned of that future happening and advised to adopt preventive measures to
halt or delay that process. This will in turn shed load from health care
resources responsible to take care of diabetic patients in the long run.
REFERENCES
1.
Sunsanee Vitha Yakul P, Singkiratana D, Bunyawant Chkuls. Risk factor based selective screening program for
Gestational Diabetes Mellitus. Siriraj Hosptial: result from clinical practice guideline. J Med
Assoc Thai 2003; 86(8): 708-14.
2.
Zargar AH, Sheikh MI, Bashi MI. Prevalence of Gestational Diabetes Mellitus in
Kashmiri women for the Indian Subcontinent. Diabetes Research Clin Pract 2004;66(2):139-45.
3.
Yogev Y, Langer O, Xenakis Em, Rosenn
B. Glucose screening in Mexican –
American women. Obstet Gynaecol
2004; 103(6): 1241-5.
4.
Tyrala EE, Reeece E. The infant of diabetic mother. Obst Gynaecol Clinics of
5.
Ben Haroush A, Yogew Y, Hod M. Epidemiology of
Gestational Diabetes Mellitus and its associate with type II l Diabetes
Mellitus. Diabet Med 2004; 21(2):103-13.
6.
Turok DK, Ratcliffe SD, Baxley EG. Patients do not need to fast
before a 50gm, one-hour glucose challenge test. Am Fam
Physician 2003;68:1768 –72.
7.
Jarett RJ. should we
screen for gestational diabetes? BMJ 1997;315:736–7.
8.
Cousins L, Dattel
BJ, Zettner A. Glycosylated
haemoglobine as a screening test for carbohydrate
intolerance in pregnancy. Am J Obst Gynaecol 1984;150: 455–60.
9.
Nasrat AA, Johnstone FD, Hasan SAM. Is random plasma glucose an
efficient screening test for abnormal glucose tolerance in pregnancy? Br J Obstet Gynaecol 1988;95:855- 60.
10. Kauntzky–Willer A, Bancher–Todesca D. Gestational
Diabetes. Wien Med Wochenschr.
2003,153(21-22);478 - 84.
11. Lolemans K, Caluwaets S, Van Assche FA. Diet induced Obesity in the rats; A model for
Gestational Diabetes Mellitus. Am J Obstet Gynaecol 2004;190(3): 858-65.
12. King
H, Rewers M. Diabetes in adults is now a third world
problem. The WHO adhoc Diabetes reporting group. Bull
WHO 1991;69:643-8
13. Lu
YP, Sun GS, Weng XY, Mao L, LI LA. Evaluation of
glucose screening. Retest during pregnancy. Zhonghua Fuchan Ke Za
Zhi 2003;38(12):729-32.
14. Di Cianni G, Volpe L, Benzil. Prevelance and risk
factors for Gestational Diabetes assessed by universal screening. Diabetes Res Clin Pract
2003;62(2):131-7.
15. Caliskan E, Kayikcioglu F, Oxturk N, Koc S, Haberal A. A population based risk factor scoring will
decrease unnecessary testing for the diagnosis of Gestational Diabetes
Mellitus. Acta Obstet Gynacol Scand 2004;83(6): 524-30.
16. O’
Sullivan JB. Diabetes mellitus after GDM. Diabetes 1991;40:131-5.
_____________________________________________________________________________________________
Address
for Correspondence:
Dr Aisha Hassan, Department of Gynaecology,
Ayub Teaching Hospital, Abbottabad. Ph: 0992 – 351-4716